DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
85 hedge funds and large institutions have $565M invested in Dicerna Pharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
85
Holders Change
+13
Holders Change %
+18.06%
% of All Funds
1.95%
Holding in Top 10
4
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-50%
% of All Funds
0.09%
New
34
Increased
22
Reduced
17
Closed
21
Calls
$4K
Puts
$1.53M
Net Calls
-$1.53M
Net Calls Change
-$360K
Top Buyers
| 1 |
1
BlackRock
New York
|
$31.9M |
| 2 |
BM
2
Bridger Management
New York
|
$39.5M |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$21M |
| 4 |
4
Adage Capital Partners
Boston,
Massachusetts
|
$30M |
| 5 |
5
State Street
Boston,
Massachusetts
|
$9.06M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
101
Jane Street
New York
| – | -$136K | -14,262 | Closed |
|
|
CC
102
Caxton Corporation
Princeton,
New Jersey
| – | -$125K | -13,074 | Closed |
|
|
LCM
103
Laurion Capital Management
New York
| – | -$112K | -11,754 | Closed |
|
|
CSS
104
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$102K | -10,665 | Closed |
|
|
SFM
105
Signet Financial Management
Parsippany,
New Jersey
| – | -$8K | -800 | Closed |
|
106
Parallax Volatility Advisers
San Francisco,
California
| – | -$8K | -798 | Closed |
|